Bone Marrow Transplant Program Receives Prestigious FACT Accreditation
February 24, 2006
The Bone Marrow Transplant Program at Dartmouth-Hitchcock Medical Center's Norris Cotton Cancer Center is now one of a select group of bone marrow transplant programs nationwide officially recognized for its overall excellence.
In February, after an extensive on-site inspection, Dartmouth's Bone Marrow Transplant Program received accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT). FACT only accredits bone marrow transplant programs that have demonstrated an exceptional level of patient care and medical and laboratory practices.
"FACT accreditation is the culmination of two to three years of preparation and work by each member of the Transplant Team. This approval further highlights the exceptional quality of our Bone Marrow Transplant Program," explained Dr. Kenneth Meehan, Director of Dartmouth's Bone Marrow Transplant Program.
Since 1984, a multidisciplinary team from the Bone Marrow Transplant Program has provided bone marrow transplantation and peripheral blood stem cell transplantation to patients, primarily those with leukemia, lymphoma, and multiple myeloma. Transplantation replaces bone marrow stem cells that have been destroyed by high doses of chemotherapy or radiation therapy with the patient's own non-cancerous cells (autologous), cells from someone other than the patient or an identical twin (allogeneic), or cells from a patient's identical twin (syngeneic).
FACT's extensive on-site inspection included every aspect of the Bone Marrow Transplant Program, from patient care and laboratory practices to administrative systems. Only a limited number of bone marrow transplant programs in the U.S. and Canada receive FACT accreditation.
FACT is a non-profit organization developed by the International Society for Cellular Therapy (ISCT) and the American Society of Blood and Marrow Transplantation (ASBMT) to establish standards for high quality medical and laboratory practice.